1. Home
  2. MLTX vs USLM Comparison

MLTX vs USLM Comparison

Compare MLTX & USLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • USLM
  • Stock Information
  • Founded
  • MLTX 2021
  • USLM 1948
  • Country
  • MLTX Switzerland
  • USLM United States
  • Employees
  • MLTX N/A
  • USLM N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • USLM Other Metals and Minerals
  • Sector
  • MLTX Health Care
  • USLM Industrials
  • Exchange
  • MLTX Nasdaq
  • USLM Nasdaq
  • Market Cap
  • MLTX 2.4B
  • USLM 3.0B
  • IPO Year
  • MLTX N/A
  • USLM N/A
  • Fundamental
  • Price
  • MLTX $41.16
  • USLM $102.11
  • Analyst Decision
  • MLTX Strong Buy
  • USLM
  • Analyst Count
  • MLTX 8
  • USLM 0
  • Target Price
  • MLTX $77.71
  • USLM N/A
  • AVG Volume (30 Days)
  • MLTX 293.0K
  • USLM 87.8K
  • Earning Date
  • MLTX 05-12-2025
  • USLM 07-30-2025
  • Dividend Yield
  • MLTX N/A
  • USLM 0.23%
  • EPS Growth
  • MLTX N/A
  • USLM 50.52
  • EPS
  • MLTX N/A
  • USLM 4.20
  • Revenue
  • MLTX N/A
  • USLM $337,287,000.00
  • Revenue This Year
  • MLTX $103.42
  • USLM $19.43
  • Revenue Next Year
  • MLTX N/A
  • USLM $13.98
  • P/E Ratio
  • MLTX N/A
  • USLM $24.38
  • Revenue Growth
  • MLTX N/A
  • USLM 17.83
  • 52 Week Low
  • MLTX $31.42
  • USLM $64.25
  • 52 Week High
  • MLTX $58.26
  • USLM $159.53
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 58.30
  • USLM 54.60
  • Support Level
  • MLTX $37.80
  • USLM $100.41
  • Resistance Level
  • MLTX $40.71
  • USLM $105.77
  • Average True Range (ATR)
  • MLTX 1.81
  • USLM 2.66
  • MACD
  • MLTX 0.14
  • USLM -0.41
  • Stochastic Oscillator
  • MLTX 99.42
  • USLM 36.57

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

Share on Social Networks: